US3861396A - Drainage tube - Google Patents

Drainage tube Download PDF

Info

Publication number
US3861396A
US3861396A US386572A US38657273A US3861396A US 3861396 A US3861396 A US 3861396A US 386572 A US386572 A US 386572A US 38657273 A US38657273 A US 38657273A US 3861396 A US3861396 A US 3861396A
Authority
US
United States
Prior art keywords
drainage tube
hydrophilic
tube
methacrylate
acrylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US386572A
Inventor
Vincent L Vaillancourt
Norman Bruckner
Edward Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valera Pharmaceuticals Inc
Original Assignee
Valera Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valera Pharmaceuticals Inc filed Critical Valera Pharmaceuticals Inc
Priority to US386572A priority Critical patent/US3861396A/en
Application granted granted Critical
Publication of US3861396A publication Critical patent/US3861396A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/44Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices
    • A61F5/441Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices having venting or deodorant means, e.g. filters ; having antiseptic means, e.g. bacterial barriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/085Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M25/005Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids

Definitions

  • ABSTRACT Means are provided for eliminating negative pressure problem, e.g. in a closed urinary system comprising a catheter, a downwardly extending tube and a collection bag.
  • the tube has an internal coating of a hydrophilic polymer, preferably a 2-hydroxyethyl methacrylate polymer, or can be made completely of the hydrophilic polymer.
  • This invention is concerned with a method for eliminating negative pressure and negative pressure build-up in the invivo and in-vitro drainage systems, more specifically for use in patients being catheterized and/or using shunts, hydro cephalic valves, etc.
  • One current drainage system consists of a catheter to which is affixed a drainage tube and a collection bag for sampling. This system is normally totally closed, with a bacterial filter vent placed in the bag.
  • a major problem with these systems is build-up of negative pressures in the bladder for example, due to the build-up of the fluids columns in the various cannulae (lumens), e.g. see Vaillancourt US. Pat. No. 3,583,401.
  • This build-up is due to a combination of: a) closed system which precludes the influence of atmospheric pressures which would break this column, and b) the surface tension of the tubing which acts to hold or retain the fluid in the tube.
  • this invention is concerned with using a hydrophilic tubing having an internal diameter of at least 0.2 inch to prevent capillary action as the connecting member (drainage tube) between the cannulae and collector. It has been found that a hydrophilic tube (having water-wetting properties) will not support a column of fluid even though a vacuum may be applied at one end.
  • the entire connecting member can be made of a water insoluble hydrophilic polymer or alternatively the hydrophilicity can be imparted to a hydrophobic tubing by coating the inside (lumen) surface of a hydrophobic plastic polymer tube with a hydrophilic polymer.
  • This form of the invention has the advantage over the use of an all hydrophilic polymer of being more economical and also of being able to take advantage of the strength, flexibility and other properties of the hydrophobic plastic.
  • hydrophilic polymer there are preferably employed polymers made from a hydrophilic monomer which are a hydroxy lower alkyl acrylate or methacrylate, or hydroxy lower alkoxy lower alkyl acrylate or methacrylate, e.g., 2-hydroxyethyl acrylate, 2- hydroxyethyl methacrylate, diethylene glycol monoacrylate, diethylene glycol monomethacrylate, 2- hydroxypropyl acrylate, Z-hydroxypropyl methacrylate, 3-hydroxypropyl acrylate, 3-hydropropyl methacrylate and dipropylene glycol monomethacrylate.
  • a hydrophilic monomer which are a hydroxy lower alkyl acrylate or methacrylate, or hydroxy lower alkoxy lower alkyl acrylate or methacrylate, e.g., 2-hydroxyethyl acrylate, 2- hydroxyethyl methacrylate, diethylene glycol monoacrylate, diethylene glycol monomethacrylate, 2-
  • the preferred monomers are hydroxyalkyl acrylates and methacrylates having 2-3 carbon atoms in the hydroxyalkyl group, most preferably Z-hydroxyethyl methacrylatc as stated above.
  • the polymers employed can be organic solvent soluble, e.g.. alcohol soluble, but are water insoluble.
  • the organic solvent soluble polymers can be prepared, for example. as shown in Shepherd U.S. Pat. No. 3,618,213 e.g., example 36 a, b and c or Chromacek US. Pat. No. 3,575,946. The entire disclosure of the Shepherd and Chromacek patents is hereby incorporated by reference.
  • the hydroxyalkyl acrylate or methacrylate less pref erably can also be replaced in whole or in part by vinyl pyrrolidone, acrylamide, methacrylamide, N-propyl acrylamide, N-isopropyl methacrylamide.
  • enthylenically unsaturated monomers can be used in conjunction with the above monomers to prepare the hydrophilic polymers.
  • The include neutral monomers such as acrylonitrile, methacrylonitrile, vinyl acetate, alkyl acrylates and methacrylates, alkoxyalkyl acrylates and methacrylates.
  • alkyl acrylates and methacrylates include methyl acrylate, ethyl acrylate, butyl acrylate, 2- ethylhexyl acrylate, methyl methacrylate and butyl methacrylates.
  • suitable alkoxyalkyl acrylates and methacrylates are methoxyethyl acrylate, methoxyethyl methacrylate, ethoxyethyl acrylate, ethoxyethyl methacrylate, propoxyethyl acrylate, butoxyethyl methacrylate, methoxypropyl acrylate, ethoxypropyl methacrylate.
  • comonomers when used in an amount preferably not higher than 50 percent (and usually between 0.5 and 20 percent) of the monomeric mixture contribute to the mechanical properties of the final gel. They should not be used in an amount to impair the hydrophilic nature of the polymer.
  • Other vinyl monomers bearing ionizable functional groups can be copolymerized with the hydroxyalkyl acrylates or methacrylates.
  • acidic type monomers such as acrylic acid, methacrylic acid, maleic acid, fumaric acid, itaconic acid, aconitic acid, cinnamic acid, crotonic acid, carboxylic acid, propiolic acid, citra conic acid, vinyl sulfonic acid, p-vinylbenzenesulfonic acid, partial esters such as mono-2-hydroxyethyl itaconate, mono-2-hydroxypropyl citraconate, mono-2- hydroxyethyl maleate, mono-Z-hydroxypropyl fumarate, monomethyl itaconate, monoethyl itaconate, monomethyl cellosolve itaconate (Methyl Cellosolve is the monoethyl ether of diethylene glycol), monomethyl Cellosolve maleate, mono-2-hydroxyethyl aconitate.
  • acidic type monomers such as acrylic acid, methacrylic acid, maleic acid, fumaric acid, itaconic acid,
  • They also include basic type monomers such as aminoethyl methacrylate, dimethyl aminoethyl methacrylate, monomethylaminoethyl methacrylate, tbutylaminoethyl methacrylate, p-aminostyrene, oaminostyrene, 2-amino-4-vinyltoluene.
  • basic type monomers such as aminoethyl methacrylate, dimethyl aminoethyl methacrylate, monomethylaminoethyl methacrylate, tbutylaminoethyl methacrylate, p-aminostyrene, oaminostyrene, 2-amino-4-vinyltoluene.
  • alkylaminoethyl acrylates and methacrylates are preferred in this group.
  • multipolymers prepared from a mixture of 3, 4 or more of the above monomers. These monomers are usually used in an amount of 0.1 20 percent, preferably 1 to 15 percent of the total monomers.
  • the final product is eventually cross-linked. This is done by sparingly cross-linking the polymer.
  • the cross-linking agent is added in an amount of l to percent most preferably, not over 2.0 percent, and still more preferably between 0.1 and 1 percent, although from 0.05 to percent or even percent of cross-linking agents can be used.
  • Cross-linking renders the otherwise solvent soluble polymers insoluble, although it does not impair the hydrophilic properties.
  • cross-linking agents include ethylene glycol diacrylate, ethylene glycol dimethacrylate, 1,4-butylene dimethacrylate, diethylene glycol dimethacrylate, propylene glycol dimethacrylate, diethylene glycol dimethacrylate, dipropylene glycol dimethacrylate, diethylene glycol diacrylate, dipropylene glycol diacrylate, divinyl benzene, divinyl toluene, diallyl tartrate, allyl pyruvate, allyl malate, divinyl tartrate, triallyl melamine, N,N'-methylene disacrylamide, diallyl maleate, divinyl ether, diallyl monoethylene glycol citrate, ethylene glycol vinyl allyl citrate, allyl vinyl maleate, diallyl itaconate, ethylene glycol diester of itaconic acid, divinyl sulfone, hexahydro-l 3, S-triacryltriazine, triallyl
  • catalysts for carrying out the polymerization there is employed a free radical catalyst in the range of 0.05 to 1 percent of the polymerizable hydroxyalkyl ester or the like.
  • the preferred amount of catalyst is 0.1 to 0.2 percent of the monomer.
  • Typical catalysts include t-butyl peroctoate, benzoyl peroxide, isopropyl percarbonate, methyl ethyl ketone peroxide, cumene hydroperoxide, and dicumyl peroxide.
  • Irradiation e.g., by ultra violet light or gamma rays, also can be employed to catalyze the polymerization. Polymerization can be done at 20 to 150C., usually 40 to 90C.
  • the solvent soluble polymers can be applied as internal coatings to tubes made of a hydrophobic polymer, and the solvent evaporated. If a cross-linking agent is present the solvent soluble polymer can then be rendered insoluble, e.g., by heating.
  • the entire tube is made of a hydrophilic polymer this can be accomplished conveniently by casting a syrup of cross-linkable partial polymer, e.g., using a casting syrup from 100 parts of 2-hydroxyethyl methacrylate and 0.2 parts of ethylene glycol dimethacrylate in the presence of a catalyst, e.g., t-butyl peroctoate,
  • hydrophilicity can be obtained by internally coating a hydrophobic plastic cannula such as polytetrafluoroethylene, tetrafluoroethylene-hexafluoropropylene copolomer, polyurethane (either of the polyester or polyether type), polyethylene, polypropylene, ethylene-propylene copolymer, ethylene-propylenenon conjugated polyene terpolymer, natural rubber, butadiene-styrene rubber, butadiene-acrylonitrile rubber, polyethylene terepthalate, polystyrene, polymethyl methacrylate, vinylidene chloride-acrylonitrile copolymer.
  • a hydrophobic plastic cannula such as polytetrafluoroethylene, tetrafluoroethylene-hexafluoropropylene copolomer, polyurethane (either of the polyester or polyether type), polyethylene, polypropylene, ethylene-propylene copolymer, ethylene-
  • the preferred hydrophobic tubing is made from a vinyl chloride polymer such as polyvinyl chloride and copolymers of vinyl chloride with vinylidene chloride, chlorostyrene, vinyl esters of carboxylic acids, e.g., vinyl acetate, vinyl propionate, vinyl butyrate and vinyl benzoate, esters of unsaturated acids, e.g., alkyl and alkenyl acrylates such as methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate and allyl acrylate as well as the corresponding methacrylates, e.g., methyl methacrylate and butyl methacrylate, vinyl aromatic compounds, e.g., styrene, p-ethyl styrene, divinyl benzene, vinyl naphthalene, a-methyl styrene, p-methyl styrene, dienes such as butadiene
  • copolymers in which at least 50 percent of the copolymers is made from vinyl chloride are preferably employed in the invention as is polyvinyl chloride.
  • Typical examples of copolymers include vinyl chloride-vinyl acetate (:5 weight ratio), vinyl chloridevinyl acetate (87:13 weight ratio), vinyl chloride-vinyl acetate-maleic anhydride (86:13:1 weight ratio), vinyl chloride-vinylidene chloride (95:5 weight ratio), vinyl chloride-diethyl fumarate (95:5 weight ratio), vinyl choloride-trichloroethylene (95:5 weight ratio).
  • the resin employed in the tubing can either be plasticized or unplasticized.
  • the plasticizer there can be employed conventional materials such as dioctyl phthalate, octyl decyl phthalate, tricresyl phosphate, 2-ethylhexyl diphenyl phosphate, dodecyl dicresyl phosphate, tributyl acetyl citrate, dioctyl sebacate, dibutyl sebacate, etc.
  • the plasticizer is used in conventional amount, e.g., 10 to parts for each 100 parts of the vinyl chloride containing resin.
  • a tubing such as polyvinyl chloride
  • the polyvinyl chloride tubing can be dipped in a casting syrup of the hydrophilic polymer and the polymer cured, e.g., there can be used a casting syrup from 98.5 percent of 2- hydroxyethyl methacrylate and 1.5 percent of ethylene glycol dimethacrylate in the manner shown in Shepherd U.S. Pat. No. 3,556,874 col. 3, lines 5-12 and in example 16.
  • lf it is not desired to coat the outside of the tube, then it can be suitably protected in the dipping process, e.g., with a removable (e.g., prelable) covermg.
  • any conventional coating process can be employed such as by spray coating or dip coating.
  • Spiral tubing can be prepared from the hydrophilic polymer either as the entire tubing or as an inner liner for polyvinyl chloride, etc., by winding on a mandrel.
  • a film of the hydrophilic polymer can be joined to one of polyvinyl chloride on a mandrel.
  • the catheter employed can be a conventional catheter. e.g., of the Foley type but preferably is a catheter of the type set forth in Shepherd US. Pat. No. 3,566,874 which has an external coating, an internal coating or both an external and internal coating of hydrophilic polymer, e.g., as set forth in examples l9 and 22 of that patent.
  • the entire disclosure of Shepherd US. Pat. No. 3,566,874 is hereby incorporated by reference.
  • the catheter can be made of natural rubber, synthetic rubber, e.g., poly cis isoprene, butadiene styrene copolymer, silicon rubber, neoprene, polyvinyl chloride, etc.
  • synthetic rubber e.g., poly cis isoprene, butadiene styrene copolymer, silicon rubber, neoprene, polyvinyl chloride, etc.
  • FIG. 1 is a plan view showing the overall apparatus of the invention
  • FIG. 2 is a fragmentary view partially in section of the drainage tube used in FIG. 1;
  • FIG. 3 is a view along the line 3--3 of FIG. 1;
  • FIG. 4 is a plan view of an alternative form of drainage tube
  • FIG. 5 is a sectional view taken along the line 55 of FIG. 4;
  • FIG. 6 is a plan view of another form of drainage tube
  • FIG. 7 is a view taken along the line 7-7 of FIG. 6;
  • FIG. 8 is a view of yet another form of drainage tube.
  • FIG. 9 is a view taken along the line 99 of FIG. 8.
  • FIG. 1 of the drawings there is shown a conventional hospital bed 2 with a patient 4, covered by sheet 6.
  • a Foley catheter 8 In the bladder of the patient there is inserted a Foley catheter 8.
  • the Foley catheter can be of conventional rubber construction but preferably the rubber has external and internal coatings of a copolymer of 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate (e.g., 99.8:0.2).
  • the catheter can be connected by a conventional adapter (not shown) to the drainage tube 10 which extends downwardly over the side of the bed and is connected to the drainage bag or receptacle 12.
  • the area of urine hold up is designated at 14.
  • the drainage tube 10 is made of polyvinyl chloride 16 and there is provided an overall internal coating 18 of hydrophilic cross-linked Z-hydroxyethyl methacrylate-ethylene glycol dimethacrylate copolymer (99.7203).
  • a drainage tube 20 of polyvinyl chloride having internal strips 22, 24, 26, 28 running throughout its length of hydrophilic polymerized 2-hydroxyethyl methacrylate.
  • FIGS. 6 and 7 show a drainage tube 30 which is made entirely of a copolymer of 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate (99.8:0.2).
  • FIGS. 8 and 9 show a polyvinyl chloride drainage tube 32 having a helical inner liner strip 34 of a 2- hydroxyethyl acrylate-ethylene glycol diacrylate copolymer (99.8:0.2).
  • hydrophobic plastic e.g., polyvinyl chloride
  • hydrophilic plastic e.g., polymerized 2- hydroxyethyl methacrylate
  • the invention has been illustrated by an urinary drainage system, the invention is also useful in draining other human and animal cavities, for example, the thoracic suprapubic and cephalic regions.
  • a means for eliminating negative pressure and negative pressure build-up in a drainage tube in a system for the drainage of liquid from a body cavity comprising a tube of said system having an internal diameter of at least 0.2 inch, said means further including a coating extending the length of the tube and on at least a part of the inner peripheral surface of the drainage tube, wherein said coating is comprised, at least in part of a hydrophilic, water-insoluble plastic.
  • drainage tube is made of a hydrophobic material and has a lumen and the lumen is coated at least in part by a geometrical arrangement of said hydrophilic plastic.
  • hydrophobic material is a vinyl chloride polymer.
  • hydrophilic plastic is a hydroxy lower alkyl acrylate or a hydroxy lower alkyl methacrylate polymer.
  • hydrophilic plastic is a 2-hydroxyethyl methacrylate polymer.

Abstract

Means are provided for eliminating negative pressure problem, e.g. in a closed urinary system comprising a catheter, a downwardly extending tube and a collection bag. The tube has an internal coating of a hydrophilic polymer, preferably a 2hydroxyethyl methacrylate polymer, or can be made completely of the hydrophilic polymer.

Description

United States Patent A 191 Jan. 21, 1975 vailla'ncourt et al;
DRAIN AGE'TUBE Inventors: Vincent L. Vaillancourt, Livingston;
Norman Bruckner, East Windsor; Edward Levine, Metuchen, all of,
NJ .1 g
Hydro MedScienceslhc New York, NY. Filed: Aug. 8, 1973 Assignee:
U.S. Cl. 128/350 R, 1.28/3-48, 128/349 R IntrCl A6lm 27/00 Field of Search 128/2 R, 349 R, 350, 275
I References Cited UNITED STATES PATENTS Wichterle et al. 128/2 R 3,566,874 3/1971 Shepherd ..12s/349 3,583,401 6/1971 Vaillancourt ..l28/275 Primary ExaminerAldrich F. Medbery Attorney, Agent, or Firm-Cushman, Darby &
Cushm-an [57] ABSTRACT Means are provided for eliminating negative pressure problem, e.g. in a closed urinary system comprising a catheter, a downwardly extending tube and a collection bag. The tube has an internal coating of a hydrophilic polymer, preferably a 2-hydroxyethyl methacrylate polymer, or can be made completely of the hydrophilic polymer.
9 Claims, 9 Drawing Figures DRAINAGE TUBE This invention is concerned with a method for eliminating negative pressure and negative pressure build-up in the invivo and in-vitro drainage systems, more specifically for use in patients being catheterized and/or using shunts, hydro cephalic valves, etc. One current drainage system consists of a catheter to which is affixed a drainage tube and a collection bag for sampling. This system is normally totally closed, with a bacterial filter vent placed in the bag. A major problem with these systems is build-up of negative pressures in the bladder for example, due to the build-up of the fluids columns in the various cannulae (lumens), e.g. see Vaillancourt US. Pat. No. 3,583,401.
This build-up is due to a combination of: a) closed system which precludes the influence of atmospheric pressures which would break this column, and b) the surface tension of the tubing which acts to hold or retain the fluid in the tube.
Methods currently used to overcome this problem include: large bore drain tubing and the placing of a vent in the catheter connector. The former solution suffers from the limitation that the product is bulky and difficult to work with, whereas the latter has been demonstrated to only work for a very short period of time before the filter element gets clogged due to infestations, and/or hydrostatic pressures. This disclosure is concerned with a novel method which allows for the use of smaller bore tubing, as well as functioning over the life of the drainage system.
Briefly, this invention is concerned with using a hydrophilic tubing having an internal diameter of at least 0.2 inch to prevent capillary action as the connecting member (drainage tube) between the cannulae and collector. It has been found that a hydrophilic tube (having water-wetting properties) will not support a column of fluid even though a vacuum may be applied at one end.
The entire connecting member can be made of a water insoluble hydrophilic polymer or alternatively the hydrophilicity can be imparted to a hydrophobic tubing by coating the inside (lumen) surface of a hydrophobic plastic polymer tube with a hydrophilic polymer. This form of the invention has the advantage over the use of an all hydrophilic polymer of being more economical and also of being able to take advantage of the strength, flexibility and other properties of the hydrophobic plastic.
As the hydrophilic polymer there are preferably employed polymers made from a hydrophilic monomer which are a hydroxy lower alkyl acrylate or methacrylate, or hydroxy lower alkoxy lower alkyl acrylate or methacrylate, e.g., 2-hydroxyethyl acrylate, 2- hydroxyethyl methacrylate, diethylene glycol monoacrylate, diethylene glycol monomethacrylate, 2- hydroxypropyl acrylate, Z-hydroxypropyl methacrylate, 3-hydroxypropyl acrylate, 3-hydropropyl methacrylate and dipropylene glycol monomethacrylate. The preferred monomers are hydroxyalkyl acrylates and methacrylates having 2-3 carbon atoms in the hydroxyalkyl group, most preferably Z-hydroxyethyl methacrylatc as stated above. The polymers employed can be organic solvent soluble, e.g.. alcohol soluble, but are water insoluble. The organic solvent soluble polymers can be prepared, for example. as shown in Shepherd U.S. Pat. No. 3,618,213 e.g., example 36 a, b and c or Chromacek US. Pat. No. 3,575,946. The entire disclosure of the Shepherd and Chromacek patents is hereby incorporated by reference.
The hydroxyalkyl acrylate or methacrylate less pref erably can also be replaced in whole or in part by vinyl pyrrolidone, acrylamide, methacrylamide, N-propyl acrylamide, N-isopropyl methacrylamide. N- methylacrylamide, N-methylmethacrylamide. N- methylol acrylamide and N-methylol methacrylamide. N-2hydroxyethyl acrylamide, N-2-hydroxyethyl methacrylamide. Since these monomers usually form water soluble homopolymers they require the presence ofsufficient cross-linking agent or copolymerization with a sufficient amount of the hydroxyalkyl acrylates and methacrylates or other material to render the copolymers water insoluble. When such monomers are employed they are usually used in an amount of 1-60 percent, preferably l25 percent, of the total monomers by weight.
Other enthylenically unsaturated monomers can be used in conjunction with the above monomers to prepare the hydrophilic polymers. The include neutral monomers such as acrylonitrile, methacrylonitrile, vinyl acetate, alkyl acrylates and methacrylates, alkoxyalkyl acrylates and methacrylates.
Examples of alkyl acrylates and methacrylates include methyl acrylate, ethyl acrylate, butyl acrylate, 2- ethylhexyl acrylate, methyl methacrylate and butyl methacrylates. Examples of suitable alkoxyalkyl acrylates and methacrylates are methoxyethyl acrylate, methoxyethyl methacrylate, ethoxyethyl acrylate, ethoxyethyl methacrylate, propoxyethyl acrylate, butoxyethyl methacrylate, methoxypropyl acrylate, ethoxypropyl methacrylate. These comonomers when used in an amount preferably not higher than 50 percent (and usually between 0.5 and 20 percent) of the monomeric mixture contribute to the mechanical properties of the final gel. They should not be used in an amount to impair the hydrophilic nature of the polymer. Other vinyl monomers bearing ionizable functional groups can be copolymerized with the hydroxyalkyl acrylates or methacrylates. They include acidic type monomers such as acrylic acid, methacrylic acid, maleic acid, fumaric acid, itaconic acid, aconitic acid, cinnamic acid, crotonic acid, carboxylic acid, propiolic acid, citra conic acid, vinyl sulfonic acid, p-vinylbenzenesulfonic acid, partial esters such as mono-2-hydroxyethyl itaconate, mono-2-hydroxypropyl citraconate, mono-2- hydroxyethyl maleate, mono-Z-hydroxypropyl fumarate, monomethyl itaconate, monoethyl itaconate, monomethyl cellosolve itaconate (Methyl Cellosolve is the monoethyl ether of diethylene glycol), monomethyl Cellosolve maleate, mono-2-hydroxyethyl aconitate.
They also include basic type monomers such as aminoethyl methacrylate, dimethyl aminoethyl methacrylate, monomethylaminoethyl methacrylate, tbutylaminoethyl methacrylate, p-aminostyrene, oaminostyrene, 2-amino-4-vinyltoluene. diethylaminoethyl acrylate, dimethylaminoethyl acrylate, tbutylaminoethyl acrylate, piperidinoethyl acrylate, piperidinoethyl methacrylate, morpholinoethyl acrylate, morpholinoethyl methacrylate, 2-vinyl pyridine, 3-vinyl pyridine, 4-vinyl pyridine, 2-ethyl-5-vinyl pyridine, dimethylaminopropyl acrylate, dimethylamino propyl methacrylate, dipropylaminoethyl acrylate. dimethylaminoethyl vinyl ether, dimethylaminoethyl vinyl sulfide, diethylaminoethyl vinyl ether, aminoethyl vinyl ether, 2-pyrrolidinoethyl methacrylate 3- (dimethylaminoethyl)-hydroxypropyl acrylate, 3-
(dimethylaminoethyl)-2-hydroxypropyl methacrylate, 2-aminoethyl acrylate, 2-aminoethyl methacrylate. The alkylaminoethyl acrylates and methacrylates are preferred in this group. In particular cases there can be used multipolymers prepared from a mixture of 3, 4 or more of the above monomers. These monomers are usually used in an amount of 0.1 20 percent, preferably 1 to 15 percent of the total monomers.
To make the final product insoluble in water (if it is not already insoluble therein) and organic solvents, it is eventually cross-linked. This is done by sparingly cross-linking the polymer. Preferably, the cross-linking agent is added in an amount of l to percent most preferably, not over 2.0 percent, and still more preferably between 0.1 and 1 percent, although from 0.05 to percent or even percent of cross-linking agents can be used. Cross-linking renders the otherwise solvent soluble polymers insoluble, although it does not impair the hydrophilic properties.
Typical examples of cross-linking agents include ethylene glycol diacrylate, ethylene glycol dimethacrylate, 1,4-butylene dimethacrylate, diethylene glycol dimethacrylate, propylene glycol dimethacrylate, diethylene glycol dimethacrylate, dipropylene glycol dimethacrylate, diethylene glycol diacrylate, dipropylene glycol diacrylate, divinyl benzene, divinyl toluene, diallyl tartrate, allyl pyruvate, allyl malate, divinyl tartrate, triallyl melamine, N,N'-methylene disacrylamide, diallyl maleate, divinyl ether, diallyl monoethylene glycol citrate, ethylene glycol vinyl allyl citrate, allyl vinyl maleate, diallyl itaconate, ethylene glycol diester of itaconic acid, divinyl sulfone, hexahydro-l 3, S-triacryltriazine, triallyl phosphite, diallyl ether of benzene phosphonic acid, polyester of maleic anhydride with triethylene glycol, diallyl aconitrate, divinyl citraconate, diallyl fumarate, ammonium dichromate. Of course toxic crosslinking agents should not be used in therapeutic applications. Cross-linking can also be accomplished with dichromates, e.g., sodium, potassium and ammonium dichromate.
As catalysts for carrying out the polymerization there is employed a free radical catalyst in the range of 0.05 to 1 percent of the polymerizable hydroxyalkyl ester or the like. The preferred amount of catalyst is 0.1 to 0.2 percent of the monomer. Usually only a portion of the catalyst, e.g. 10-20 percent is added initially to the monomer and the balance is added to the casting syrup after partial polymerization. Typical catalysts include t-butyl peroctoate, benzoyl peroxide, isopropyl percarbonate, methyl ethyl ketone peroxide, cumene hydroperoxide, and dicumyl peroxide. Irradiation, e.g., by ultra violet light or gamma rays, also can be employed to catalyze the polymerization. Polymerization can be done at 20 to 150C., usually 40 to 90C.
The solvent soluble polymers can be applied as internal coatings to tubes made of a hydrophobic polymer, and the solvent evaporated. If a cross-linking agent is present the solvent soluble polymer can then be rendered insoluble, e.g., by heating.
It the entire tube is made of a hydrophilic polymer this can be accomplished conveniently by casting a syrup of cross-linkable partial polymer, e.g., using a casting syrup from 100 parts of 2-hydroxyethyl methacrylate and 0.2 parts of ethylene glycol dimethacrylate in the presence of a catalyst, e.g., t-butyl peroctoate,
such as the casting syrup in Shepherd U.S. Pat. No. 3,618,213, example 12 h and then curing to form a hydrophilic, water insoluble tube.
Alternatively instead of using hydrophilic polymer tubing the hydrophilicity can be obtained by internally coating a hydrophobic plastic cannula such as polytetrafluoroethylene, tetrafluoroethylene-hexafluoropropylene copolomer, polyurethane (either of the polyester or polyether type), polyethylene, polypropylene, ethylene-propylene copolymer, ethylene-propylenenon conjugated polyene terpolymer, natural rubber, butadiene-styrene rubber, butadiene-acrylonitrile rubber, polyethylene terepthalate, polystyrene, polymethyl methacrylate, vinylidene chloride-acrylonitrile copolymer. The preferred hydrophobic tubing is made from a vinyl chloride polymer such as polyvinyl chloride and copolymers of vinyl chloride with vinylidene chloride, chlorostyrene, vinyl esters of carboxylic acids, e.g., vinyl acetate, vinyl propionate, vinyl butyrate and vinyl benzoate, esters of unsaturated acids, e.g., alkyl and alkenyl acrylates such as methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate and allyl acrylate as well as the corresponding methacrylates, e.g., methyl methacrylate and butyl methacrylate, vinyl aromatic compounds, e.g., styrene, p-ethyl styrene, divinyl benzene, vinyl naphthalene, a-methyl styrene, p-methyl styrene, dienes such as butadiene and isoprene, unsaturated amides such as acrylamide, methacrylamide and acrylanilide and the esters of a, B-unsaturated carboxylic acids, e.g., the methyl, ethyl, propyl, butyl, amyl, hexyl, heptyl, octyl, allyl, methallyl and phenyl esters of maleic, crotonic, itaconic and fumaric acids and the like. Specific examples of such esters are diethyl maleate, dibutyl maleate and dibutyl fumarate.
The copolymers in which at least 50 percent of the copolymers is made from vinyl chloride are preferably employed in the invention as is polyvinyl chloride.
Typical examples of copolymers include vinyl chloride-vinyl acetate (:5 weight ratio), vinyl chloridevinyl acetate (87:13 weight ratio), vinyl chloride-vinyl acetate-maleic anhydride (86:13:1 weight ratio), vinyl chloride-vinylidene chloride (95:5 weight ratio), vinyl chloride-diethyl fumarate (95:5 weight ratio), vinyl choloride-trichloroethylene (95:5 weight ratio).
The resin employed in the tubing, e.g., polyvinyl chloride, can either be plasticized or unplasticized. As the plasticizer there can be employed conventional materials such as dioctyl phthalate, octyl decyl phthalate, tricresyl phosphate, 2-ethylhexyl diphenyl phosphate, dodecyl dicresyl phosphate, tributyl acetyl citrate, dioctyl sebacate, dibutyl sebacate, etc. The plasticizer is used in conventional amount, e.g., 10 to parts for each 100 parts of the vinyl chloride containing resin.
When a tubing such as polyvinyl chloride is coated with the hydrophilic polymer, this can be accomplished in any convenient fashion. Thus the polyvinyl chloride tubing can be dipped in a casting syrup of the hydrophilic polymer and the polymer cured, e.g., there can be used a casting syrup from 98.5 percent of 2- hydroxyethyl methacrylate and 1.5 percent of ethylene glycol dimethacrylate in the manner shown in Shepherd U.S. Pat. No. 3,556,874 col. 3, lines 5-12 and in example 16. lf it is not desired to coat the outside of the tube, then it can be suitably protected in the dipping process, e.g., with a removable (e.g., prelable) covermg.
Any conventional coating process can be employed such as by spray coating or dip coating. There likewise can be used coextrusion so that the hydrophilic polymer is extruded as an integral inner concentric tubular liner for the polyvinyl chloride or other hydrophobic polymer. Spiral tubing can be prepared from the hydrophilic polymer either as the entire tubing or as an inner liner for polyvinyl chloride, etc., by winding on a mandrel. A film of the hydrophilic polymer can be joined to one of polyvinyl chloride on a mandrel.
The catheter employed can be a conventional catheter. e.g., of the Foley type but preferably is a catheter of the type set forth in Shepherd US. Pat. No. 3,566,874 which has an external coating, an internal coating or both an external and internal coating of hydrophilic polymer, e.g., as set forth in examples l9 and 22 of that patent. The entire disclosure of Shepherd US. Pat. No. 3,566,874 is hereby incorporated by reference.
The catheter can be made of natural rubber, synthetic rubber, e.g., poly cis isoprene, butadiene styrene copolymer, silicon rubber, neoprene, polyvinyl chloride, etc.
The invention will be understood best in connection with the drawings wherein:
FIG. 1 is a plan view showing the overall apparatus of the invention;
FIG. 2 is a fragmentary view partially in section of the drainage tube used in FIG. 1;
FIG. 3 is a view along the line 3--3 of FIG. 1;
FIG. 4 is a plan view of an alternative form of drainage tube;
FIG. 5 is a sectional view taken along the line 55 of FIG. 4;
FIG. 6 is a plan view of another form of drainage tube;
FIG. 7 is a view taken along the line 7-7 of FIG. 6;
FIG. 8 is a view of yet another form of drainage tube; and
FIG. 9 is a view taken along the line 99 of FIG. 8.
Referring more specifically to FIG. 1 of the drawings there is shown a conventional hospital bed 2 with a patient 4, covered by sheet 6. In the bladder of the patient there is inserted a Foley catheter 8. The Foley catheter can be of conventional rubber construction but preferably the rubber has external and internal coatings of a copolymer of 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate (e.g., 99.8:0.2). The catheter can be connected by a conventional adapter (not shown) to the drainage tube 10 which extends downwardly over the side of the bed and is connected to the drainage bag or receptacle 12. The area of urine hold up is designated at 14.
As shown in FIGS. 2 and 3 the drainage tube 10 is made of polyvinyl chloride 16 and there is provided an overall internal coating 18 of hydrophilic cross-linked Z-hydroxyethyl methacrylate-ethylene glycol dimethacrylate copolymer (99.7203).
As shown in FIGS. 4 and 5 there is provided a drainage tube 20 of polyvinyl chloride having internal strips 22, 24, 26, 28 running throughout its length of hydrophilic polymerized 2-hydroxyethyl methacrylate.
FIGS. 6 and 7 show a drainage tube 30 which is made entirely of a copolymer of 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate (99.8:0.2).
FIGS. 8 and 9 show a polyvinyl chloride drainage tube 32 having a helical inner liner strip 34 of a 2- hydroxyethyl acrylate-ethylene glycol diacrylate copolymer (99.8:0.2).
It is also possible to employ a tube extruded from a mixture of hydrophobic plastic, e.g., polyvinyl chloride and hydrophilic plastic, e.g., polymerized 2- hydroxyethyl methacrylate.
While the invention has been illustrated by an urinary drainage system, the invention is also useful in draining other human and animal cavities, for example, the thoracic suprapubic and cephalic regions.
What is claimed is:
l. A means for eliminating negative pressure and negative pressure build-up in a drainage tube in a system for the drainage of liquid from a body cavity comprising a tube of said system having an internal diameter of at least 0.2 inch, said means further including a coating extending the length of the tube and on at least a part of the inner peripheral surface of the drainage tube, wherein said coating is comprised, at least in part of a hydrophilic, water-insoluble plastic.
2. The means of claim I wherein the inner surface of the drainage tube is composed of said hydrophilic plas- 3. The system of claim 2 wherein the entire drainage tube is made of said hydrophilic plastic.
4. The means of claim 2 wherein the drainage tube is made of a hydrophobic material and has a lumen and the lumen is coated at least in part by a geometrical arrangement of said hydrophilic plastic.
5. The means of claim 4 wherein the lumen is completely coated by said hydrophilic plastic.
6. The means of claim 4 wherein the hydrophobic material is a vinyl chloride polymer.
7. The means according to claim 6 wherein the lumen is completely coated by said hydrophilic plastic.
8. The means according to claim 7 wherein the hydrophilic plastic is a hydroxy lower alkyl acrylate or a hydroxy lower alkyl methacrylate polymer.
9. The means according to claim 8 wherein the hydrophilic plastic is a 2-hydroxyethyl methacrylate polymer.

Claims (9)

1. A MEANS FOR ELIMINATING NEGATIVE PRESSURE AND NEGATIVE PRESSURE BUILD-UP IN A DRAINAGE TUBE IN A SYSTEM FOR THE DRAINAGE OF LIQUID FROM A BODY CAVITY COMPRISING A TUBE OF SAID SYSTEM HAVING AN INTERNAL DIAMETER OF AT LEAST 0.2 INCH, SAID MEANS FURTHER INCLUDING A COATING EXTENDING THE LENGTH OF THE TUBE AND ON AT LEAST A PART OF THE INNER PERIPHERAL SURFACE OF THE DRAINAGE TUBE, WHEREIN SAID COATING IS COMPRISED, AT LEAST IN PART OF A HYDROPHILLIC, WATER-INSOLUBLE PLASTIC.
2. The means of claim 1 wherein the inner surface of the drainage tube is composed of said hydrophilic plastic.
3. The system of claim 2 wherein the entire drainage tube is made of said hydrophilic plastic.
4. The means of claim 2 wherein the drainage tube is made of a hydrophobic material and has a lumen and the lumen is coated at least in part by a geometrical arrangement of said hydrophilic plastic.
5. The means of claim 4 wherein the lumen is completely coatEd by said hydrophilic plastic.
6. The means of claim 4 wherein the hydrophobic material is a vinyl chloride polymer.
7. The means according to claim 6 wherein the lumen is completely coated by said hydrophilic plastic.
8. The means according to claim 7 wherein the hydrophilic plastic is a hydroxy lower alkyl acrylate or a hydroxy lower alkyl methacrylate polymer.
9. The means according to claim 8 wherein the hydrophilic plastic is a 2-hydroxyethyl methacrylate polymer.
US386572A 1973-08-08 1973-08-08 Drainage tube Expired - Lifetime US3861396A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US386572A US3861396A (en) 1973-08-08 1973-08-08 Drainage tube

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US386572A US3861396A (en) 1973-08-08 1973-08-08 Drainage tube

Publications (1)

Publication Number Publication Date
US3861396A true US3861396A (en) 1975-01-21

Family

ID=23526156

Family Applications (1)

Application Number Title Priority Date Filing Date
US386572A Expired - Lifetime US3861396A (en) 1973-08-08 1973-08-08 Drainage tube

Country Status (1)

Country Link
US (1) US3861396A (en)

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995628A (en) * 1975-04-25 1976-12-07 Travenol Laboratories, Inc. Catheter insertion device
US4276874A (en) * 1978-11-15 1981-07-07 Datascope Corp. Elongatable balloon catheter
WO1981002982A1 (en) * 1980-04-22 1981-10-29 Key Pharma Inhalation spirometric device for administering pulmonary medication
US4306557A (en) * 1978-08-29 1981-12-22 North Daniel A Vacuum urological surgical irrigating solution collecting system
US4459318A (en) * 1981-11-09 1984-07-10 American Hospital Supply Corporation Method for forming a self-lubricating fill tube
US4469483A (en) * 1982-08-25 1984-09-04 Baxter Travenol Laboratories, Inc. Radiopaque catheter
US4484577A (en) * 1981-07-23 1984-11-27 Key Pharmaceuticals, Inc. Drug delivery method and inhalation device therefor
US4516970A (en) * 1982-09-13 1985-05-14 Kaufman Jack W Medical device
US4557724A (en) * 1981-02-17 1985-12-10 University Of Utah Research Foundation Apparatus and methods for minimizing cellular adhesion on peritoneal injection catheters
US4601286A (en) * 1984-04-20 1986-07-22 Kaufman Jack W Article for the protection of living tissues
US4668224A (en) * 1983-10-24 1987-05-26 Warner-Lambert Company Oxidized cellulose as a medical lubricant
US4755171A (en) * 1987-05-29 1988-07-05 Tennant Jerald L Tubular surgical device
US4773902A (en) * 1983-10-24 1988-09-27 Deseret Medical, Inc. Oxidized cellulose as a medical lubricant
US4781703A (en) * 1985-10-17 1988-11-01 Menlo Care, Inc. Catheter assembly
US4798597A (en) * 1987-04-29 1989-01-17 Sherwood Medical Co Flexible composite intubation tube
US4861617A (en) * 1987-07-20 1989-08-29 Pall Corporation Method of reducing the adhesion of bubbles in medical equipment
US4959150A (en) * 1988-09-26 1990-09-25 Pall Corporation Fluid treatment system having low affinity for proteinaceous materials
US4994047A (en) * 1988-05-06 1991-02-19 Menlo Care, Inc. Multi-layer cannula structure
US5000731A (en) * 1989-03-30 1991-03-19 Tai-Ting Wong Shunting device adopted in the intracranial shunting surgical operation for the treatment of hydrocephalus
US5004461A (en) * 1989-03-23 1991-04-02 Wilson Joseph E Methods for rendering plastics thromboresistant and product
US5135516A (en) * 1989-12-15 1992-08-04 Boston Scientific Corporation Lubricious antithrombogenic catheters, guidewires and coatings
EP0502714A1 (en) * 1991-03-04 1992-09-09 Critikon, Inc. Use of surfactants to improve intravenous catheter flashback
US5217026A (en) * 1992-04-06 1993-06-08 Kingston Technologies, Inc. Guidewires with lubricious surface and method of their production
US5356400A (en) * 1993-05-06 1994-10-18 Temple John E Large bore drainage apparatus
US5368048A (en) * 1993-04-19 1994-11-29 Stoy; George P. Method of making radio-opaque tipped, sleeved guidewire and product
US5397306A (en) * 1989-12-20 1995-03-14 Terumo Kabushiki Kaisha Catheter
US5443907A (en) * 1991-06-18 1995-08-22 Scimed Life Systems, Inc. Coating for medical insertion guides
US5472435A (en) * 1993-05-21 1995-12-05 Navarre Biomedical, Ltd. Drainage catheter
US5554147A (en) * 1994-02-01 1996-09-10 Caphco, Inc. Compositions and devices for controlled release of active ingredients
US5603991A (en) * 1995-09-29 1997-02-18 Target Therapeutics, Inc. Method for coating catheter lumens
US5779686A (en) * 1993-04-19 1998-07-14 Olympus Optical Co., Ltd. Disposable medical instrument
US5788687A (en) * 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5800412A (en) * 1996-10-10 1998-09-01 Sts Biopolymers, Inc. Hydrophilic coatings with hydrating agents
EP0945148A1 (en) * 1998-03-26 1999-09-29 Biomat B.V. Endovascular stents with a polymeric coating
US5967714A (en) * 1997-03-06 1999-10-19 Huels Aktiengesellschaft Process for the preparation of antimicrobial plastics
WO2004004611A1 (en) * 2002-07-08 2004-01-15 Coloplast A/S Conduit device
WO2004004796A1 (en) * 2002-07-08 2004-01-15 Coloplast A/S External urinary catheter
US20040107477A1 (en) * 2002-12-10 2004-06-10 Kimberly-Clark Worldwide, Inc. Crosslinking agent for coated elastomeric articles
US6755824B2 (en) 2002-04-15 2004-06-29 Uab Research Foundation Platelet inhibitor eluting ablation catheter
US20050090891A1 (en) * 1989-12-15 2005-04-28 Sahatjian Ronald A. Stent lining
US20050107720A1 (en) * 1991-06-18 2005-05-19 Burmeister Paul H. Intravascular guide wire and method for manufacture thereof
US20050171496A1 (en) * 2002-07-08 2005-08-04 Guldfeldt Signe U. Conduit device
WO2006044621A2 (en) * 2004-10-15 2006-04-27 The Regents Of The University Of California Improved drainage system
US20090005762A1 (en) * 2007-06-26 2009-01-01 Vasu Nishtala Bioabsorbable Drain Tube
US20090182288A1 (en) * 2008-01-04 2009-07-16 Spenciner David B Flexible Medical Cannula
EP2180914A1 (en) * 2007-07-16 2010-05-05 Med-I-Dynamix Fluid Monitoring Ltd. Systems and methods for removal of urine
US20110238163A1 (en) * 2008-09-08 2011-09-29 Laboratorios Farmaceuticos Rovi S.A. Multi-layered Device
US20120184944A1 (en) * 2011-01-19 2012-07-19 Tomes Jennifer E Coiled Tubing for Drain Bag Applications
US20120221009A1 (en) * 2011-02-28 2012-08-30 Terumo Kabushiki Kaisha Medical device and vascularization method
US8480227B2 (en) 2010-07-30 2013-07-09 Novartis Ag Silicone hydrogel lenses with water-rich surfaces
US9005700B2 (en) 2011-10-12 2015-04-14 Novartis Ag Method for making UV-absorbing ophthalmic lenses
USD737429S1 (en) * 2012-06-13 2015-08-25 Vijay A. Doraiswamy Medical tube with radio-opaque double helix indicia
US9708087B2 (en) 2013-12-17 2017-07-18 Novartis Ag Silicone hydrogel lens with a crosslinked hydrophilic coating
US9925355B2 (en) 2012-11-12 2018-03-27 Hollister Incorporated Intermittent catheter assembly and kit
US10220185B2 (en) 2012-11-14 2019-03-05 Hollister Incorporated Disposable catheter with selectively degradable inner core
US10338408B2 (en) 2012-12-17 2019-07-02 Novartis Ag Method for making improved UV-absorbing ophthalmic lenses
US10420859B2 (en) 2013-12-12 2019-09-24 Hollister Incorporated Flushable catheters
US10426918B2 (en) 2013-12-12 2019-10-01 Hollister Incorporated Flushable catheters
US10449740B2 (en) 2015-12-15 2019-10-22 Novartis Ag Method for applying stable coating on silicone hydrogel contact lenses
US10463833B2 (en) 2013-12-12 2019-11-05 Hollister Incorporated Flushable catheters
WO2020167649A1 (en) * 2019-02-15 2020-08-20 California Institute Of Technology Tear flow measurement device
US10821209B2 (en) 2013-11-08 2020-11-03 Hollister Incorporated Oleophilic lubricated catheters
US10830923B2 (en) 2017-12-13 2020-11-10 Alcon Inc. Method for producing MPS-compatible water gradient contact lenses
US10874769B2 (en) 2013-12-12 2020-12-29 Hollister Incorporated Flushable disintegration catheter
US11002884B2 (en) 2014-08-26 2021-05-11 Alcon Inc. Method for applying stable coating on silicone hydrogel contact lenses
US11185613B2 (en) 2015-06-17 2021-11-30 Hollister Incorporated Selectively water disintegrable materials and catheters made of such materials
WO2021242676A1 (en) * 2020-05-27 2021-12-02 Hollister Incorporated Multi-flex urinary catheter

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
US3566874A (en) * 1968-08-13 1971-03-02 Nat Patent Dev Corp Catheter
US3583401A (en) * 1969-01-21 1971-06-08 Bard Inc C R Vented closed drainage system with double lumen tube

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
US3566874A (en) * 1968-08-13 1971-03-02 Nat Patent Dev Corp Catheter
US3583401A (en) * 1969-01-21 1971-06-08 Bard Inc C R Vented closed drainage system with double lumen tube

Cited By (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995628A (en) * 1975-04-25 1976-12-07 Travenol Laboratories, Inc. Catheter insertion device
US4306557A (en) * 1978-08-29 1981-12-22 North Daniel A Vacuum urological surgical irrigating solution collecting system
US4276874A (en) * 1978-11-15 1981-07-07 Datascope Corp. Elongatable balloon catheter
WO1981002982A1 (en) * 1980-04-22 1981-10-29 Key Pharma Inhalation spirometric device for administering pulmonary medication
JPS57500591A (en) * 1980-04-22 1982-04-08
US4557724A (en) * 1981-02-17 1985-12-10 University Of Utah Research Foundation Apparatus and methods for minimizing cellular adhesion on peritoneal injection catheters
US4484577A (en) * 1981-07-23 1984-11-27 Key Pharmaceuticals, Inc. Drug delivery method and inhalation device therefor
US4459318A (en) * 1981-11-09 1984-07-10 American Hospital Supply Corporation Method for forming a self-lubricating fill tube
US4469483A (en) * 1982-08-25 1984-09-04 Baxter Travenol Laboratories, Inc. Radiopaque catheter
US4516970A (en) * 1982-09-13 1985-05-14 Kaufman Jack W Medical device
US4668224A (en) * 1983-10-24 1987-05-26 Warner-Lambert Company Oxidized cellulose as a medical lubricant
US4773902A (en) * 1983-10-24 1988-09-27 Deseret Medical, Inc. Oxidized cellulose as a medical lubricant
US4601286A (en) * 1984-04-20 1986-07-22 Kaufman Jack W Article for the protection of living tissues
US4781703A (en) * 1985-10-17 1988-11-01 Menlo Care, Inc. Catheter assembly
US4798597A (en) * 1987-04-29 1989-01-17 Sherwood Medical Co Flexible composite intubation tube
AU610578B2 (en) * 1987-04-29 1991-05-23 Sherwood Medical Company A flexible composite intubation tube
US4755171A (en) * 1987-05-29 1988-07-05 Tennant Jerald L Tubular surgical device
US4861617A (en) * 1987-07-20 1989-08-29 Pall Corporation Method of reducing the adhesion of bubbles in medical equipment
US4994047A (en) * 1988-05-06 1991-02-19 Menlo Care, Inc. Multi-layer cannula structure
US4959150A (en) * 1988-09-26 1990-09-25 Pall Corporation Fluid treatment system having low affinity for proteinaceous materials
US5004461A (en) * 1989-03-23 1991-04-02 Wilson Joseph E Methods for rendering plastics thromboresistant and product
US5000731A (en) * 1989-03-30 1991-03-19 Tai-Ting Wong Shunting device adopted in the intracranial shunting surgical operation for the treatment of hydrocephalus
US20050090891A1 (en) * 1989-12-15 2005-04-28 Sahatjian Ronald A. Stent lining
US5135516A (en) * 1989-12-15 1992-08-04 Boston Scientific Corporation Lubricious antithrombogenic catheters, guidewires and coatings
US7371257B2 (en) 1989-12-15 2008-05-13 Boston Scientific Scimed, Inc. Stent lining
US5397306A (en) * 1989-12-20 1995-03-14 Terumo Kabushiki Kaisha Catheter
EP0502714A1 (en) * 1991-03-04 1992-09-09 Critikon, Inc. Use of surfactants to improve intravenous catheter flashback
US5443907A (en) * 1991-06-18 1995-08-22 Scimed Life Systems, Inc. Coating for medical insertion guides
US7214201B2 (en) 1991-06-18 2007-05-08 Boston Scientific Scimed, Inc. Intravascular guide wire and method for manufacture thereof
US7063674B2 (en) 1991-06-18 2006-06-20 Scimed Life Systems, Inc. Intravascular guide wire and method for manufacture thereof
US20060129066A1 (en) * 1991-06-18 2006-06-15 Burmeister Paul H Intravascular guide wire and method for manufacture thereof
US6908443B2 (en) 1991-06-18 2005-06-21 Scimed Life Systems, Inc. Intravascular guide wire and method for manufacture thereof
US20050119590A1 (en) * 1991-06-18 2005-06-02 Burmeister Paul H. Intravascular guide wire and method for manufacture thereof
US20050107720A1 (en) * 1991-06-18 2005-05-19 Burmeister Paul H. Intravascular guide wire and method for manufacture thereof
US5217026A (en) * 1992-04-06 1993-06-08 Kingston Technologies, Inc. Guidewires with lubricious surface and method of their production
US6203856B1 (en) 1993-03-06 2001-03-20 Huels Aktiengesellschaft Process for the preparation of antimicrobial plastics
US5368048A (en) * 1993-04-19 1994-11-29 Stoy; George P. Method of making radio-opaque tipped, sleeved guidewire and product
US5779686A (en) * 1993-04-19 1998-07-14 Olympus Optical Co., Ltd. Disposable medical instrument
US5356400A (en) * 1993-05-06 1994-10-18 Temple John E Large bore drainage apparatus
US5472435A (en) * 1993-05-21 1995-12-05 Navarre Biomedical, Ltd. Drainage catheter
US5788687A (en) * 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US6306422B1 (en) 1994-02-01 2001-10-23 Caphco, Inc. Compositions and devices for controlled release of active ingredients
US5554147A (en) * 1994-02-01 1996-09-10 Caphco, Inc. Compositions and devices for controlled release of active ingredients
US5607417A (en) * 1994-02-01 1997-03-04 Caphco, Inc. Compositions and devices for controlled release of active ingredients
US5603991A (en) * 1995-09-29 1997-02-18 Target Therapeutics, Inc. Method for coating catheter lumens
US5800412A (en) * 1996-10-10 1998-09-01 Sts Biopolymers, Inc. Hydrophilic coatings with hydrating agents
US5967714A (en) * 1997-03-06 1999-10-19 Huels Aktiengesellschaft Process for the preparation of antimicrobial plastics
EP0945148A1 (en) * 1998-03-26 1999-09-29 Biomat B.V. Endovascular stents with a polymeric coating
US6755824B2 (en) 2002-04-15 2004-06-29 Uab Research Foundation Platelet inhibitor eluting ablation catheter
WO2004004611A1 (en) * 2002-07-08 2004-01-15 Coloplast A/S Conduit device
US20050171496A1 (en) * 2002-07-08 2005-08-04 Guldfeldt Signe U. Conduit device
US20050177133A1 (en) * 2002-07-08 2005-08-11 Nielsen Henrik L. External urinary catheter
WO2004004796A1 (en) * 2002-07-08 2004-01-15 Coloplast A/S External urinary catheter
US20040107477A1 (en) * 2002-12-10 2004-06-10 Kimberly-Clark Worldwide, Inc. Crosslinking agent for coated elastomeric articles
US7032251B2 (en) 2002-12-10 2006-04-25 Kimberly-Clark Worldwide, Inc. Crosslinking agent for coated elastomeric articles
WO2006044621A2 (en) * 2004-10-15 2006-04-27 The Regents Of The University Of California Improved drainage system
US20060271019A1 (en) * 2004-10-15 2006-11-30 The Regents Of The University Of California Drainage system
WO2006044621A3 (en) * 2004-10-15 2009-05-07 Univ California Improved drainage system
US20090005762A1 (en) * 2007-06-26 2009-01-01 Vasu Nishtala Bioabsorbable Drain Tube
CN103550853B (en) * 2007-07-16 2015-11-18 弗罗森斯有限公司 For removing the system and method for urine
EP2180914A1 (en) * 2007-07-16 2010-05-05 Med-I-Dynamix Fluid Monitoring Ltd. Systems and methods for removal of urine
US20170232227A1 (en) * 2007-07-16 2017-08-17 Flowsense Ltd. Systems and methods for removal of urine
US10617843B2 (en) * 2007-07-16 2020-04-14 Flowsense Ltd. Systems and methods for removal of urine
US9687628B2 (en) 2007-07-16 2017-06-27 Flowsense Ltd. Systems and methods for removal of urine
US20090182288A1 (en) * 2008-01-04 2009-07-16 Spenciner David B Flexible Medical Cannula
US20110238163A1 (en) * 2008-09-08 2011-09-29 Laboratorios Farmaceuticos Rovi S.A. Multi-layered Device
US9411171B2 (en) 2010-07-30 2016-08-09 Novartis Ag Silicone hydrogel lenses with water-rich surfaces
US9244200B2 (en) 2010-07-30 2016-01-26 Novartis Ag Silicone hydrogel lenses with water-rich surfaces
US9816009B2 (en) 2010-07-30 2017-11-14 Novartis Ag Silicone hydrogel lenses with water-rich surfaces
US9738813B2 (en) 2010-07-30 2017-08-22 Novartis Ag Silicone hydrogel lens with a crosslinked hydrophilic coating
US10781340B2 (en) 2010-07-30 2020-09-22 Alcon Inc. Silicone hydrogel lenses with water-rich surfaces
US8939577B2 (en) 2010-07-30 2015-01-27 Novartis Ag Silicone hydrogel lenses with water-rich surfaces
US9239409B2 (en) 2010-07-30 2016-01-19 Novartis Ag Silicone hydrogel lens with a crosslinked hydrophilic coating
US8944592B2 (en) 2010-07-30 2015-02-03 Novartis Ag Silicone hydrogel lens with a crosslinked hydrophilic coating
US8529057B2 (en) 2010-07-30 2013-09-10 Novartis Ag Silicone hydrogel lens with a crosslinked hydrophilic coating
US9507173B2 (en) 2010-07-30 2016-11-29 Novartis Ag Silicone hydrogel lens with a crosslinked hydrophilic coating
US8480227B2 (en) 2010-07-30 2013-07-09 Novartis Ag Silicone hydrogel lenses with water-rich surfaces
US20120184944A1 (en) * 2011-01-19 2012-07-19 Tomes Jennifer E Coiled Tubing for Drain Bag Applications
US20120221009A1 (en) * 2011-02-28 2012-08-30 Terumo Kabushiki Kaisha Medical device and vascularization method
US9101418B2 (en) * 2011-02-28 2015-08-11 Terumo Kabushiki Kaisha Medical device and vascularization method
US9005700B2 (en) 2011-10-12 2015-04-14 Novartis Ag Method for making UV-absorbing ophthalmic lenses
USD737429S1 (en) * 2012-06-13 2015-08-25 Vijay A. Doraiswamy Medical tube with radio-opaque double helix indicia
US9925355B2 (en) 2012-11-12 2018-03-27 Hollister Incorporated Intermittent catheter assembly and kit
US10220185B2 (en) 2012-11-14 2019-03-05 Hollister Incorporated Disposable catheter with selectively degradable inner core
US10338408B2 (en) 2012-12-17 2019-07-02 Novartis Ag Method for making improved UV-absorbing ophthalmic lenses
US11833274B2 (en) 2013-11-08 2023-12-05 Hollister Incorporated Oleophilic lubricated catheters
US10821209B2 (en) 2013-11-08 2020-11-03 Hollister Incorporated Oleophilic lubricated catheters
US10463833B2 (en) 2013-12-12 2019-11-05 Hollister Incorporated Flushable catheters
US11318279B2 (en) 2013-12-12 2022-05-03 Hollister Incorporated Flushable catheters
US10426918B2 (en) 2013-12-12 2019-10-01 Hollister Incorporated Flushable catheters
US10420859B2 (en) 2013-12-12 2019-09-24 Hollister Incorporated Flushable catheters
US10874769B2 (en) 2013-12-12 2020-12-29 Hollister Incorporated Flushable disintegration catheter
US9708087B2 (en) 2013-12-17 2017-07-18 Novartis Ag Silicone hydrogel lens with a crosslinked hydrophilic coating
US11002884B2 (en) 2014-08-26 2021-05-11 Alcon Inc. Method for applying stable coating on silicone hydrogel contact lenses
US11185613B2 (en) 2015-06-17 2021-11-30 Hollister Incorporated Selectively water disintegrable materials and catheters made of such materials
US10449740B2 (en) 2015-12-15 2019-10-22 Novartis Ag Method for applying stable coating on silicone hydrogel contact lenses
US11029446B2 (en) 2017-12-13 2021-06-08 Alcon Inc. Method for producing MPS-compatible water gradient contact lenses
US11029447B2 (en) 2017-12-13 2021-06-08 Alcon Inc. Method for producing MPS-compatible water gradient contact lenses
US10830923B2 (en) 2017-12-13 2020-11-10 Alcon Inc. Method for producing MPS-compatible water gradient contact lenses
US11256003B2 (en) 2017-12-13 2022-02-22 Alcon Inc. Weekly and monthly disposable water gradient contact lenses
US20200260946A1 (en) * 2019-02-15 2020-08-20 California Institute Of Technology Tear Flow Measurement Device
US11730358B2 (en) * 2019-02-15 2023-08-22 California Institute Of Technology Tear flow measurement device
WO2020167649A1 (en) * 2019-02-15 2020-08-20 California Institute Of Technology Tear flow measurement device
WO2021242676A1 (en) * 2020-05-27 2021-12-02 Hollister Incorporated Multi-flex urinary catheter

Similar Documents

Publication Publication Date Title
US3861396A (en) Drainage tube
US4773901A (en) Catheter with selectively rigidified portion
US4424311A (en) Antithrombogenic biomedical material
CA1191064A (en) Catheter with selectively rigidified portion
US3695921A (en) Method of coating a catheter
US3566874A (en) Catheter
EP0063897B1 (en) Line for use in body fluid treatment
US5294401A (en) Membrane type of oxygenator and method for production thereof
US5538512A (en) Lubricious flow directed catheter
US5503631A (en) Lubricious catheter balloon for vasodilation
US4055682A (en) Catheter and the method of making
US4623329A (en) Drainage and infusion catheters having a capillary sleeve forming a reservoir for a fluid antimicrobial agent
EP0611576B1 (en) Medical tool having lubricious surface in a wetted state and method for production thereof
US2972349A (en) Capillary oxygenator
EP1192959B1 (en) Antithrombotic surface treating agent and medical apparatus
JP3334934B2 (en) Hydrophobic polymer composite membrane
SE8006151L (en) MICROPOROS MOVIES AND PROCEDURES
CN114805897A (en) Super-hydrophilic antibacterial silicone tube and preparation method and application thereof
WO1997041901B1 (en) Pentosanpolysulfate coating for medical devices
JP3282831B2 (en) Catheter tube
JP3580844B2 (en) Medical device with lubricious surface when wet
JPS5857186B2 (en) The basics of the future
JPH09225037A (en) Dispenser for guide wire
Glahn Influence of drainage conditions on mucosal bladder damage by indwelling catheters: I. Pressure study
CN217091581U (en) Ureteral stent